tirzepatide crohn's GLP-1 for Disease: Current Evidence and Treatment Options COMMIT-CD: A Phase 3b trial

Key resources include: ClinicalTrials.gov Search for new trials involving cagrilintide or retatrutide PubMed/MEDLINE Set alerts for publications on these compounds Major medical journals New England Journal of Medicine, The Lancet, JAMA for high-impact studies Endocrine Society conferences Annual meetings where phase 3 data is often first presented FDA briefing documents Detailed safety and efficacy data released during approval processes Understanding the broader landscape of peptide research helps contextualize developments with specific compounds

Detcheverry, F., Senthil, S., Narayanan, S., & Badhwar, A

Identification of the insulin-like growth factor binding proteins 5 and 6 (IGFBP-5 and 6) in human breast cancer cells

Alli BY et al

GLP-1 receptor agonist medicines such as Wegovy (semaglutide) and Mounjaro (tirzepatide) are designed to be taken once a week on a regular schedule